Mar 02, 2023 8:45am EST Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels
Feb 21, 2023 9:00am EST Lexaria Discovers Potential Novel Mechanism From Hypertension Study HYPER-H21-4
Jan 23, 2023 8:45am EST Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor
Nov 29, 2022 8:50am EST Lexaria’s DehydraTECH-CBD(TM) Enhances Performance Compared to Epidiolex(R) in Seizure Study Program
